215 related articles for article (PubMed ID: 21212317)
21. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
[TBL] [Abstract][Full Text] [Related]
22. Oral and dental aspects of Sjögren's syndrome.
Leonard G; Flint S
J Ir Dent Assoc; 2006; 52(3):130-6. PubMed ID: 17205841
[TBL] [Abstract][Full Text] [Related]
23. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome.
Wei P; Li C; Qiang L; He J; Li Z; Hua H
Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e156-60. PubMed ID: 25475778
[TBL] [Abstract][Full Text] [Related]
24. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
25. Oral manifestations of Sjögren's syndrome.
Mathews SA; Kurien BT; Scofield RH
J Dent Res; 2008 Apr; 87(4):308-18. PubMed ID: 18362310
[TBL] [Abstract][Full Text] [Related]
26. Salivary anti-spectrin autoantibodies in Sjögren's syndrome.
Moody M; Zipp M; Al-Hashimi I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630
[TBL] [Abstract][Full Text] [Related]
27. IgV peptide mapping of native Ro60 autoantibody proteomes in primary Sjögren's syndrome reveals molecular markers of Ro/La diversification.
Wang JJ; Al Kindi MA; Colella AD; Dykes L; Jackson MW; Chataway TK; Reed JH; Gordon TP
Clin Immunol; 2016 Dec; 173():57-63. PubMed ID: 27609500
[TBL] [Abstract][Full Text] [Related]
28. Urban legends series: Sjögren's syndrome.
Aframian DJ; Konttinen YT; Carrozzo M; Tzioufas AG
Oral Dis; 2013 Jan; 19(1):46-58. PubMed ID: 22490059
[TBL] [Abstract][Full Text] [Related]
29. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjögren's syndrome patients and healthy controls.
Garberg H; Jonsson R; Brokstad KA
Scand J Rheumatol; 2005; 34(1):49-55. PubMed ID: 15903026
[TBL] [Abstract][Full Text] [Related]
30. Immune response against the coiled coil domain of Sjögren's syndrome associated autoantigen Ro52 induces salivary gland dysfunction.
Sroka M; Bagavant H; Biswas I; Ballard A; Deshmukh US
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):41-46. PubMed ID: 29465352
[TBL] [Abstract][Full Text] [Related]
31. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
32. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.
Staikou EV; Routsias JG; Makri AA; Terzoglou A; Sakarellos-Daitsiotis M; Sakarellos C; Panayotou G; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2003 Oct; 134(1):143-50. PubMed ID: 12974767
[TBL] [Abstract][Full Text] [Related]
33. Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA.
Mekinian A; Nicaise-Roland P; Chollet-Martin S; Fain O; Crestani B
Rheumatology (Oxford); 2013 Dec; 52(12):2223-8. PubMed ID: 24026249
[TBL] [Abstract][Full Text] [Related]
34. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
[TBL] [Abstract][Full Text] [Related]
35. Anti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjögren's syndrome using luciferase immunoprecipitation systems (LIPS).
Volchenkov R; Jonsson R; Appel S
Scand J Rheumatol; 2012 Aug; 41(4):314-5. PubMed ID: 22804348
[No Abstract] [Full Text] [Related]
36. Salivary autoantibodies in HIV-associated salivary gland disease.
Atkinson JC; Schiødt M; Robataille S; Greenspan D; Greenspan JS; Fox PC
J Oral Pathol Med; 1993 May; 22(5):203-6. PubMed ID: 8315599
[TBL] [Abstract][Full Text] [Related]
37. Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren's syndrome and Sicca.
Chiang S; Grogan T; Kamounah S; Wei F; Tayob N; Kim JY; Kyun Park J; Akin D; Elashoff DA; Pedersen AML; Song YW; Wong DTW; Chia D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599651
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies.
Armağan B; Robinson SA; Bazoberry A; Perin J; Grader-Beck T; Akpek EK; Kim J; Baer AN
Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1559-1565. PubMed ID: 33742788
[TBL] [Abstract][Full Text] [Related]
39. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
40. The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndrome.
Song JS; Do JH; Lee SW
Rheumatol Int; 2012 Feb; 32(2):491-5. PubMed ID: 21246358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
